RNVU1-29

Across TCGA pan-cancer cohorts, RNVU1-29 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RNVU1-29’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RNVU1-29 RNA is repressed in tumor relative to normal tissue. In most cancer types RNVU1-29 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

THCA, KIRC, and CHOL are the cancer types where RNVU1-29 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNVU1-29 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	IV	−2.100	<.001	11	view →
KIRC	Male	All	+0.150	.002	5	view →
CHOL	All	II,III,IV	+0.525	<.001	3	view →
PRAD	All	All	+0.307	.025	2	view →
LIHC	All	II,III,IV	+0.077	.024	2	view →
KICH	All	All	−0.115	.012	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RNVU1-29–THCA

Open the THCA breakdown →